NCOR1 and breast cancer: Low expression of NCOR1 is associated with acquired tamoxifen resistance in a mouse model of BC.29 Recent data have also shown that decreased NCOR1 expression is significantly associated with shorter RFS in BC patients, suggesting a poor prognosis30 that may be related to immune system involvement and enhanced drug resistance.